LexDanaLexDanabeta
Inventor

NIDHI ARORA

Inventor
US

Overview

6→
Patents
2022–2025
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
12,448,363Kinase inhibitors202512,371,435Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors202512,065,446Inhibitors of Bruton's tyrosine kinase and method of their use202411,485,738Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors202211,319,329Inhibitors of Bruton's tyrosine kinase and methods of their use202211,220,509Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors2022

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2022–2025Patents assigned to MIRATI THERAPEUTICS INC (3)· patent assignee history
2022–2024Patents assigned to JANSSEN PHARMACEUTICA NV (2)· patent assignee history
2022–2025Based in US· patent location history
2025Patents assigned to VIDYA THERAPEUTICS INC (1)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MIRATI THERAPEUTICS INC32022–2025
JANSSEN PHARMACEUTICA NV22022–2024
VIDYA THERAPEUTICS INC12025
Locations
LocationPatentsSpan
US62022–2025